ANTARES PHARMA, INC. Insider Trading for July 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANTARES PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANTARES PHARMA, INC. for July 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 22 2015 | ATRS | ANTARES PHARMA, IN ... | HOBBS EAMONN P | President & CEO | Payment of Exercise | F | 2.41 | 9,264 | 22,326 | 435,990 | 445.3 K to 436 K (-2.08 %) |
Jul 21 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.14 | 31,261 | 66,995 | 6,111,957 | 6.1 M to 6.1 M (-0.51 %) |
Jul 21 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.14 | 39,787 | 85,268 | 7,778,852 | 7.8 M to 7.8 M (-0.51 %) |
Jul 21 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.13 | 4,048 | 8,622 | 6,143,218 | 6.1 M to 6.1 M (-0.07 %) |
Jul 21 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.13 | 5,152 | 10,974 | 7,818,639 | 7.8 M to 7.8 M (-0.07 %) |
Jul 21 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.12 | 3,245 | 6,879 | 6,147,266 | 6.2 M to 6.1 M (-0.05 %) |
Jul 21 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.12 | 4,131 | 8,758 | 7,823,791 | 7.8 M to 7.8 M (-0.05 %) |
Jul 21 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.11 | 8,096 | 17,083 | 6,150,511 | 6.2 M to 6.2 M (-0.13 %) |
Jul 21 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.11 | 10,304 | 21,741 | 7,827,922 | 7.8 M to 7.8 M (-0.13 %) |
Jul 21 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.20 | 55,338 | 121,921 | 6,158,607 | 6.2 M to 6.2 M (-0.89 %) |
Jul 21 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.20 | 70,431 | 155,174 | 7,838,226 | 7.9 M to 7.8 M (-0.89 %) |
Jul 16 2015 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | SVP General Counsel ... | Option Exercise | A | 2.29 | 125,000 | 286,250 | 125,000 | |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.07 | 19,598 | 40,501 | 6,213,945 | 6.2 M to 6.2 M (-0.31 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.07 | 24,943 | 51,547 | 7,908,657 | 7.9 M to 7.9 M (-0.31 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.06 | 43,956 | 90,330 | 6,233,543 | 6.3 M to 6.2 M (-0.70 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.06 | 55,944 | 114,965 | 7,933,600 | 8 M to 7.9 M (-0.70 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.05 | 43,956 | 89,890 | 6,277,499 | 6.3 M to 6.3 M (-0.70 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.05 | 55,944 | 114,405 | 7,989,544 | 8 M to 8 M (-0.70 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.06 | 44,000 | 90,420 | 6,321,455 | 6.4 M to 6.3 M (-0.69 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.06 | 56,000 | 115,080 | 8,045,488 | 8.1 M to 8 M (-0.69 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.05 | 44,000 | 89,980 | 6,365,455 | 6.4 M to 6.4 M (-0.69 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.05 | 56,000 | 114,520 | 8,101,488 | 8.2 M to 8.1 M (-0.69 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.10 | 41,650 | 87,369 | 6,409,455 | 6.5 M to 6.4 M (-0.65 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.10 | 53,009 | 111,197 | 8,157,488 | 8.2 M to 8.2 M (-0.65 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.09 | 24,108 | 50,395 | 6,451,105 | 6.5 M to 6.5 M (-0.37 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.09 | 30,684 | 64,142 | 8,210,497 | 8.2 M to 8.2 M (-0.37 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.09 | 2,244 | 4,679 | 6,475,213 | 6.5 M to 6.5 M (-0.03 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.09 | 2,856 | 5,955 | 8,241,181 | 8.2 M to 8.2 M (-0.03 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.09 | 3,476 | 7,247 | 6,477,457 | 6.5 M to 6.5 M (-0.05 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.09 | 4,424 | 9,224 | 8,244,037 | 8.2 M to 8.2 M (-0.05 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.08 | 15,928 | 33,130 | 6,480,933 | 6.5 M to 6.5 M (-0.25 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.08 | 20,272 | 42,166 | 8,248,461 | 8.3 M to 8.2 M (-0.25 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.12 | 67,577 | 143,371 | 6,496,861 | 6.6 M to 6.5 M (-1.03 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.12 | 86,007 | 182,472 | 8,268,733 | 8.4 M to 8.3 M (-1.03 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.12 | 16,689 | 35,362 | 6,564,438 | 6.6 M to 6.6 M (-0.25 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.12 | 21,240 | 45,005 | 8,354,740 | 8.4 M to 8.4 M (-0.25 %) |
Jul 01 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.11 | 4,664 | 9,841 | 6,581,127 | 6.6 M to 6.6 M (-0.07 %) |
Jul 01 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.11 | 5,936 | 12,525 | 8,375,980 | 8.4 M to 8.4 M (-0.07 %) |
Jul 01 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.10 | 14,624 | 30,735 | 6,585,791 | 6.6 M to 6.6 M (-0.22 %) |
Jul 01 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.10 | 18,612 | 39,117 | 8,381,916 | 8.4 M to 8.4 M (-0.22 %) |
Jul 01 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.08 | 136,170 | 283,887 | 6,600,415 | 6.7 M to 6.6 M (-2.02 %) |
Jul 01 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.08 | 173,307 | 361,310 | 8,400,528 | 8.6 M to 8.4 M (-2.02 %) |
Jul 01 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.08 | 69,914 | 145,757 | 3,388,846 | 3.5 M to 3.4 M (-2.02 %) |
Jul 01 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.08 | 82,300 | 170,962 | 6,736,585 | 6.8 M to 6.7 M (-1.21 %) |
Jul 01 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.08 | 104,745 | 217,587 | 8,573,835 | 8.7 M to 8.6 M (-1.21 %) |
Jul 01 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.08 | 42,255 | 87,776 | 3,458,760 | 3.5 M to 3.5 M (-1.21 %) |
Jul 01 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.18 | 21,784 | 47,406 | 6,818,885 | 6.8 M to 6.8 M (-0.32 %) |
Jul 01 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.18 | 27,726 | 60,337 | 8,678,580 | 8.7 M to 8.7 M (-0.32 %) |
Jul 01 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.18 | 11,185 | 24,341 | 3,501,015 | 3.5 M to 3.5 M (-0.32 %) |